TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 1 filers reported holding TURNING POINT THERAPEUTICS I in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $16,606,000 | +646.3% | 220,676 | +166.3% | 0.26% | +611.1% |
| Q1 2022 | $2,225,000 | -53.7% | 82,856 | -17.7% | 0.04% | -47.8% |
| Q4 2021 | $4,801,000 | +43.9% | 100,644 | +100.4% | 0.07% | +27.8% |
| Q3 2021 | $3,337,000 | -9.0% | 50,228 | +6.9% | 0.05% | -20.6% |
| Q2 2021 | $3,667,000 | -16.1% | 47,000 | +1.7% | 0.07% | -29.9% |
| Q1 2021 | $4,370,000 | -64.8% | 46,200 | -76.8% | 0.10% | -80.9% |
| Q4 2019 | $12,419,000 | – | 199,378 | – | 0.51% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 3,037,042 | $236,950,000 | 8.05% |
| MPM BioImpact LLC | 269,186 | $21,002,000 | 3.45% |
| Logos Global Management LP | 400,000 | $31,208,000 | 2.62% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 121,541 | $9,481,000 | 2.50% |
| Orbimed Advisors | 2,361,327 | $184,231,000 | 1.86% |
| First Light Asset Management, LLC | 395,825 | $30,882,000 | 1.85% |
| SECTORAL ASSET MANAGEMENT INC | 211,650 | $16,513,000 | 1.34% |
| Nicholas Investment Partners, LP | 224,876 | $17,545,000 | 1.10% |
| DAFNA Capital Management LLC | 47,852 | $3,733,000 | 0.78% |
| Eventide Asset Management | 578,000 | $45,096,000 | 0.61% |